World Study results strengthen the case for using Regeneron’s antibody cocktail in high-risk Covid patients. March 23, 2021March 23, 2021Rebecca RobbinsComments Off on Study results strengthen the case for using Regeneron’s antibody cocktail in high-risk Covid patients. The treatment sharply cut the risk of hospitalization and death in a large clinical trial, the drug maker announced.
